Science
Flexible and protected – EurekAlert
In the fight against the coronavirus, SARS-CoV-2 researchers from multiple research institutions in Germany have combined their resources to study the spike protein on the surface of the virus. With its spikes, the virus binds to human cells and infects them.…
At the start of a COVID-19 infection, the coronavirus SARS-CoV-2 docks onto human cells using the spike-like proteins on its surface. The spike protein is at the centre of vaccine development because it triggers an immune response in humans. A group of German scientists, including members of the European Molecular Biology Laboratory (EMBL) in Heidelberg, the Max Planck Institute of Biophysics, the Paul-Ehrlich-Institut, and Goethe University Frankfurt have focused on the surface structure of the…
-
Noosa News18 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News24 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Business23 hours agoAre BHP shares are buy after its results?
-
Business13 hours agoprofit up 7%, guidance strong